AI assistant
Sending…
LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2012
May 16, 2012
33431_dirs_2012-05-16_1cf22cde-52dc-4a88-882d-d2ff165f48cb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2012-02-15
Reporting Person: STEELE GARY T (Director, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-15 | Common Stock | M | 100000 | $6.13 | Acquired | 180800 | Indirect |
| 2012-05-15 | Common Stock | M | 95048 | $6.65 | Disposed | 85752 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-15 | NonQualified Stock Option | $6.13 | M | 100000 | Disposed | 2012-05-19 | Common Stock (100000) | Direct |
Footnotes
F1: Mr Steele surrendered to the Issuer the right to receive an aggregate of 95,048 shares of Common Stock. Mr Steele did not sell any Common Stock in connection with the foregoing exercise.
More from LIFECORE BIOMEDICAL, INC. \DE\
Regulatory Filings
2026
Jun 5
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Jan 16
Investor Presentation
2025
Nov 17
Interim / Quarterly Report
2025
Nov 6
Earnings Release
2025
Nov 6
Declaration of Voting Results & Voting Rights Announcements
2025
Oct 31
Major Shareholding Notification
2025
Oct 17